Patents by Inventor Christian Schudt

Christian Schudt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Roflumilast for the treatment of pulmonary hypertension
    Patent number: 8648100
    Abstract: The invention relates to the use of Roflumilast, Roflumilast N-Oxide or a pharmaceutically acceptable salt of either for the treatment of pulmonary hypertension. The invention additionally relates to the use of Roflumilast, Roflumilast N-oxide or a pharmaceutically acceptable salt of either in combination with a PDE5 inhibitor or a pharmaceutically acceptable salt thereof for the treatment of pulmonary hypertension.
    Type: Grant
    Filed: April 12, 2006
    Date of Patent: February 11, 2014
    Assignee: Takeda GmbH
    Inventors: Rolf Beume, Armin Hatzelmann, Degenhard Marx, Christian Schudt, Hermann Tenor, Saadia Eddahibi, Serge Adnot
  • Use for PDE5 inhibitors
    Patent number: 8278300
    Abstract: The present invention is concerned with the use of PDE5 inhibitors in medicine.
    Type: Grant
    Filed: January 4, 2010
    Date of Patent: October 2, 2012
    Assignee: Nycomed GmbH
    Inventors: Torsten Dunkern, Christian Schudt, Friedrich Grimminger, Hossein Ardeschir Ghofrani, Manfred Kaps, Bernhard Rosengarten
  • COMPOSITION COMPRISING A PDE4 INHIBITOR AND A PDE5 INHIBITOR
    Publication number: 20120196867
    Abstract: The claimed subject matter relates to pharmaceutical compositions comprising a PDE4 inhibitor and a PDE5 inhibitor and the treatment of a disease in which phosphodiesterase 4 (PDE4) and/or phosphodiesterase 5 (PDE5) is detrimental.
    Type: Application
    Filed: April 12, 2012
    Publication date: August 2, 2012
    Applicant: NYCOMED GMBH
    Inventors: Torsten DUNKERN, Armin HATZELMANN, Christian SCHUDT, Friedrich GRIMMINGER, Hossein Ardeschir GHOFRANI
  • COMPOSITION COMPRISING A PDE4 INHIBITOR AND A PDE5 INHIBITOR
    Publication number: 20100234382
    Abstract: The invention relates to the combined administration of a PDE4 inhibitor and a PDE5 inhibitor for the treatment of a disease in which phosphodiesterase 4 (PDE4) and/or phosphodiesterase 5 (PDE5) is detrimental.
    Type: Application
    Filed: May 24, 2010
    Publication date: September 16, 2010
    Applicant: NYCOMED GMBH
    Inventors: Torsten DUNKERN, Armin HATZELMANN, Christian SCHUDT, Friedrich GRIMMINGER, Hossein Ardeschir GHOFRANI
  • Novel use for PDE5 inhibitors
    Publication number: 20100179152
    Abstract: The present invention is concerned with the use of PDE5 inhibitors in medicine.
    Type: Application
    Filed: January 4, 2010
    Publication date: July 15, 2010
    Applicant: NYCOMED GmbH
    Inventors: Torsten Dunkern, Christian Schudt, Friedrich Grimminger, Hossein Ardeschir Ghofrani, Manfred Kaps, Bernhard Rosengarten
  • Use for PDE5 inhibitors
    Patent number: 7666872
    Abstract: The present invention is concerned with the use of PDE5 inhibitors in medicine.
    Type: Grant
    Filed: March 3, 2005
    Date of Patent: February 23, 2010
    Assignee: NYCOMED GmbH
    Inventors: Torsten Dunkern, Christian Schudt, Friedrich Grimminger, Hossein Ardeschir Ghofrani, Manfred Kaps, Bernhard Rosengarten
  • Roflumilast for the Treatment of Pulmonary Hypertension
    Publication number: 20090215836
    Abstract: The invention relates to the use of Roflumilast, Roflumilast N-Oxide or a pharmaceutically acceptable salt of either for the treatment of pulmonary hypertension. The invention additionally relates to the use of Roflumilast, Roflumilast N-oxide or a pharmaceutically acceptable salt of either in combination with a PDE5 inhibitor or a pharmaceutically acceptable salt thereof for the treatment of pulmonary hypertension.
    Type: Application
    Filed: April 12, 2006
    Publication date: August 27, 2009
    Applicant: NYCOMED GMBH
    Inventors: Rolf Beume, Armin Hatzelmann, Degenhard Marx, Christian Schudt, Hermann Tenor, Saadia Eddahibi, Serge Adnot
  • Combination of a Pd4 Inhibitor and a Tetrahydrobiopterin Derivative
    Publication number: 20080221111
    Abstract: The invention describes the use of a PDE4 inhibitor in combination with BH4 or a BH4 derivative for the prevention and/or treatment of respiratory diseases.
    Type: Application
    Filed: May 8, 2006
    Publication date: September 11, 2008
    Applicant: NYCOMED GmbH
    Inventors: Christian Hesslinger, Christian Schudt, Degenhard Marx, Clemens Braun
  • Novel use for pde5 inhibitors
    Publication number: 20070185114
    Abstract: The present invention is concerned with the use of PDE5 inhibitors in medicine.
    Type: Application
    Filed: March 3, 2005
    Publication date: August 9, 2007
    Applicant: ALTANA PHARMA AG
    Inventors: Torsten Dunkern, Christian Schudt, Friedrich Grimminger, Hossein Ghofrani, Manfred Kaps, Bernhard Rosengarten
  • Use of bh4 for the treatment of respiratory diseases
    Publication number: 20070049599
    Abstract: The invention describes the use of Tetrahydrobiopterin (BH4) or derivatives thereof for the treatment of COPD. In a preferred embodiment, BH4 or derivates thereof are combined with arginine or derivatives thereof.
    Type: Application
    Filed: October 29, 2004
    Publication date: March 1, 2007
    Applicant: Altana Pharma AG
    Inventors: Christian Hesslinger, Wolf-Ruediger Ulrich, Christian Schudt
  • Synergistic combination
    Publication number: 20060205806
    Abstract: The invention relates to the combined administration of PDE inhibitors and ?2 adrenoceptor agonists for the treatment of respiratory disorders.
    Type: Application
    Filed: May 15, 2006
    Publication date: September 14, 2006
    Inventors: Ulrich Kilian, Christian Schudt
  • Pde4 inhibitors for the treatment of neoplasms of lymphoid cells
    Publication number: 20060148804
    Abstract: The invention relates to the use of certain PDE4 inhibitors alone or in combination with one or more differentiation inducing agents and/or an agent effective in raising intracellular concentrations of cAMP or a stable analogue of cAMP in the preparation of pharmaceutical compositions for the treatment of neoplasms of lymphoid cells.
    Type: Application
    Filed: January 14, 2004
    Publication date: July 6, 2006
    Inventors: Jurgen Braunger, Christian Schudt
  • Synergistic combination
    Patent number: 7056936
    Abstract: The invention relates to the combined administration of PDE inhibitors and ?2 adrenoceptor agonists for the treatment of respiratory tract disorders.
    Type: Grant
    Filed: May 14, 2003
    Date of Patent: June 6, 2006
    Assignee: Altana Pharma AG
    Inventors: Ulrich Kilian, Christian Schudt
  • Composition comprising a pde4 inhibitor and a pde5 inhibitor
    Publication number: 20060094723
    Abstract: The invention relates to the combined administration of a PDE4 inhibitor and a PDE5 inhibitor for the treatment of a disease in which phosphodiesterase 4 (PDE4) and/or phosphodiesterase 5 (PDE5) is detrimental.
    Type: Application
    Filed: May 19, 2004
    Publication date: May 4, 2006
    Inventors: Torsten Dunkern, Armin Hatzelmann, Christian Schudt
  • Synergistic combination
    Publication number: 20060079539
    Abstract: The invention relates to the combined administration of PDE inhibitors and ?2 adrenoceptor agonists for the treatment of respiratory disorders.
    Type: Application
    Filed: November 25, 2005
    Publication date: April 13, 2006
    Inventors: Ulrich Kilian, Christian Schudt
  • Substituted diaminopyrimidines
    Publication number: 20050222186
    Abstract: The invention relates to substituted diaminopyrimidine compounds, which are effective therapeutic compounds for treating diseases and disorders associated with those commonly treated by Protein Kinase C theta (PKC?) inhibitors.
    Type: Application
    Filed: June 7, 2003
    Publication date: October 6, 2005
    Applicant: Altana Pharma AG
    Inventors: Monika Baudler, Shripad Bhagwat, Paul Erdman, Florian Gantner, Moorthy Palanki, Christian Schudt, Josef Stadlwieser, James Zapf
  • Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency
    Publication number: 20050181066
    Abstract: The invention relates to the novel use of guanylate cyclase activators for the treatment of partial and global respiratory failure.
    Type: Application
    Filed: April 24, 2003
    Publication date: August 18, 2005
    Applicant: Altana Pharma AG
    Inventors: Friedrich Grimminger, Ralph Schermuly, Christian Schudt
  • Novel use of selective pde5 inhibitors
    Publication number: 20050107394
    Abstract: The invention relates to the novel use of PDE5 inhibitors for the treatment of patients in which a mismatch is present.
    Type: Application
    Filed: December 14, 2002
    Publication date: May 19, 2005
    Inventors: Ardeschir Ghofrani, Friedrich Grimminger, Christian Schudt
  • Synergistic combination
    Publication number: 20040034087
    Abstract: The invention relates to the combined administration of PDE inhibitors and &bgr;2 adrenoceptor agonists for the treatment of respiratory tract disorders.
    Type: Application
    Filed: May 14, 2003
    Publication date: February 19, 2004
    Applicant: ALTANA PHARMA AG
    Inventors: Ulrich Kilian, Christian Schudt
  • Synergistic combination
    Patent number: 6624181
    Abstract: The invention relates to the combined administration of PDE inhibitors and &bgr;2 adrenoceptor agonists for the treatment of respiratory tract disorders.
    Type: Grant
    Filed: February 20, 2002
    Date of Patent: September 23, 2003
    Assignee: Altana Pharma AG
    Inventors: Ulrich Kilian, Christian Schudt